Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. I. Peinado, M. M. Musri, M. Vives, M. Diez, S. Pizarro, E. Ferrer, R. Bastos, R. Rodriguez-Roisin, J. A. Barberà (Barcelona, Spain). Gene expression of angiogenic factors in pulmonary arteries from COPD. Eur Respir J 2009; 34: Suppl. 53, 1590

Member's Comments

No comment yet.

Related content which might interest you: microRNAs are deregulated in pulmonary arteries from COPD patients Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012 The gene expression of the endothelial to mesenchymal transition-related transcription factor slug is increased in remodelled pulmonary arteries of COPD Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 The transcription factor slug is increased in pulmonary artery endothelial cells of COPD patients Source: Annual Congress 2013 –Pulmonary circulation: basic science Year: 2013 Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD Year: 2009 Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion Source: Eur Respir J 2008; 31: 135-139 Year: 2008 Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003 Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patients Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Cigarette smoking alters microRNA expression profiling and contributes to pulmonary artery remodeling via targeting connective tissue growth factor Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Pulmonary gene expression of tenascin-C and fibronectin in chronic obtructive pulmonary disease (COPD) Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments Year: 2012 Expression of fetal genes in pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 microRNA-34a and microRNA 199a-5p in COPD and their control of HIF-1α expression in pulmonary vasucular endothelial cells Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations Source: Eur Respir Rev 2014; 23: 350-355 Year: 2014 Gene therapeutic approaches: from stem cell therapy to gene delivery Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006 microRNA profiling in pulmonary fibroblasts in COPD Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011